20 Jan Centrose secures another patent for CarboConnect
Madison, Wis. – Centrose, a Madison-based biopharmaceutical company, has secured another patent from the United States Patent and Trademark Office.
The company, which has developed new sugar chemistry for use in drug development, received the patent for a piece of CarboConnect, a platform technology discovered by company co-founder Jon Thorson. The patent is licensed through the Wisconsin Alumni Research Foundation.
Centrose and pharmaceutical partners use the platform to improve drugs through a special sugar attachment. The attachment has shown he ability to improve a drug’s potency, solubility, and distribution.
James Prudent, chief executive officer of Centrose, said CarboConnect can improve the efficacy of a wide variety of drugs. He also said Centrose has decided to look for potential partners that want to enhance their lead drug candidates.